Skip to main content
. 2019 Mar 26;60(5):1043–1049. doi: 10.1194/jlr.M090951

TABLE 4.

Interaction between ELOVL2/5 haplotype and DHA intake on breast-milk PUFA level

LA GLA DGLA ARA DTA ALA EPA DHA
coef P coef P coef P coef P coef P coef P coef P coef P
ELOVL2
 Q1a Reference
 Q2a −0.0243 0.644 −0.0161 0.344 −0.0047 0.567 −0.0053 0.635 −0.0012 0.654 −0.0099 0.643 −0.0084 0.333 −0.0031 0.876
 H1b Reference
 H2b −0.0723 0.046 −0.0205 0.093 −0.0065 0.253 −0.0125 0.107 −0.0022 0.251 −0.0253 0.083 −0.0143 0.022 −0.0364 0.008
 Q1-H1c Reference
 Q2-H2c 0.1107 0.038 0.0329 0.060 0.0108 0.192 0.0255 0.025 0.0040 0.143 0.0385 0.072 0.0190 0.034 0.0586 0.004
ELOVL5
 Q1a Reference
 Q2a −0.0144 0.790 −0.0144 0.406 −0.0023 0.780 0.0005 0.967 −0.0004 0.891 −0.0327 0.128 −0.0102 0.246 −0.0193 0.342
 Q4a −0.0450 0.374 −0.0126 0.437 −0.0072 0.345 −0.0136 0.204 −0.0024 0.351 −0.0223 0.267 −0.0020 0.812 0.0036 0.851
 H1b Reference
 H4b −0.0546 0.376 −0.0280 0.157 −0.0098 0.295 −0.0145 0.264 −0.0040 0.205 −0.0131 0.595 −0.0168 0.095 −0.0329 0.157
 H5b −0.0086 0.886 0.0081 0.672 0.0031 0.736 −0.0043 0.735 −0.0011 0.721 −0.0034 0.886 −0.0106 0.273 −0.0172 0.473
 Q1-H1c Reference
 Q2-H4c 0.0341 0.699 0.0213 0.455 0.0030 0.829 0.0093 0.615 0.0003 0.953 0.0679 0.053 0.0072 0.611 0.0434 0.185
 Q4-H4c 0.1994 0.068 0.0603 0.084 0.0385 0.020 0.0326 0.159 0.0046 0.409 0.0998 0.022 0.0359 0.042 0.0621 0.129
 Q2-H5c 0.1158 0.238 0.0250 0.452 0.0318 0.036 0.0382 0.069 0.0083 0.099 0.0527 0.182 0.0424 0.011 0.0550 0.141
 Q4-H5c −0.0068 0.944 0.0446 0.162 0.0059 0.694 0.0029 0.887 0.0020 0.695 −0.0055 0.885 0.0393 0.015 0.0600 0.124
a

Quartile level of DHA intake. Q1: < 14.58 mg/day (reference); Q2: 14.58–43.15 mg/day; and Q4: ≥118.82 mg/day.

b

Type of haplotype. ELOVL2, H1: A-C-C (reference); ELOVL2, H2: A-G-G; ELOVL5, H1: C-A-C-G-A (reference); ELOVL5, H4: A-A-C-A-A; and ELOVL5, H5: C-A-C-A-A. Haplotypes are named according to their frequency.

c

Effect of interaction between DHA intake and haplotype on PUFA levels compared with the reference.